Join to access to all OVN content. Join for Free
How to Start Presenting Like a Pro
Master Presenter Medical Science Liaisons Presentation Skills Virtual Presence Key Opinion Leaders Storytelling Techniques AI Assessment Tools Interview Skills

How to Start Presenting Like a Pro


Share This Article


Summary

In this episode, Tom Caravela is joined by Sarah Snyder and Patrina Pellett to share expert advice on how to become a master presenter. They explore and discuss the many ways Medical Science Liaisons can improve their presentation skills through proven training methods and practices. The discussion highlights the evolution of MSL presentations as well as interview presentations emphasizing key components like virtual presence and properly engaging Key Opinion Leaders (KOLs). They also cover improving storytelling, energy, and interview skills, while discussing new AI assessment tools that is bringing MSLs to an entirely new level.

Key Points

  • Listening to and critiquing your own past performances is crucial for improving presentation skills.
  • Practicing with AI tools can provide immediate, data-driven feedback that helps refine presentation techniques.
  • Customizing presentation training to address individual and real-life scenarios can significantly enhance an MSL's effectiveness and confidence.

Click for Source
Master Presenter, Medical Science Liaisons, Presentation Skills, Virtual Presence, Key Opinion Leaders, Storytelling Techniques, AI Assessment Tools, Interview Skills

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation
Partner Avatar Bridget Rasmusson

Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
The Strategic vs the Scientific MSL
Partner Avatar MSL Talk: Tom Caravela, Joy Morrell

The Strategic vs the Scientific MSL

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Explore OVN